Related Experiment Video
Updated: Mar 30, 2026
Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
Published on: February 22, 2015
Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans
Annie S Tam1, Jeffrey S C Chu2, Ann M Rose3
1Department of Medical Genetics, University of British Columbia, Vancouver, V6T 1Z3, Canada Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, V5Z 1L3, Canada atam@bccrc.ca.
Abstract:
Cancer therapy largely depends on chemotherapeutic agents that generate DNA lesions. However, our understanding of the nature of the resulting lesions as well as the mutational profiles of these chemotherapeutic agents is limited. Among these lesions, DNA interstrand crosslinks are among the more toxic types of DNA damage. Here, we have characterized the mutational spectrum of the commonly used DNA interstrand crosslinking agent mitomycin C (MMC). Using a combination of genetic mapping, whole genome sequencing, and genomic analysis, we have identified and confirmed several genomic lesions linked to MMC-induced DNA damage in Caenorhabditis elegans. Our data indicate that MMC predominantly causes deletions, with a 5'-CpG-3' sequence context prevalent in the deleted regions of DNA. Furthermore, we identified microhomology flanking the deletion junctions, indicative of DNA repair via nonhomologous end joining. Based on these results, we propose a general repair mechanism that is likely to be involved in the biological response to this highly toxic agent. In conclusion, the systematic study we have described provides insight into potential sequence specificity of MMC with DNA.
Insights
Mitomycin C (MMC) causes DNA deletions, particularly at 5'-CpG-3' sites, in cancer therapy. DNA repair mechanisms like nonhomologous end joining are involved in processing these MMC-induced genomic lesions.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Chemotherapeutic agents are crucial in cancer therapy, inducing DNA lesions.
- Understanding the specific DNA lesions and mutational profiles caused by these agents is limited.
- DNA interstrand crosslinks represent a particularly toxic class of DNA damage.
Purpose of the Study:
- To characterize the mutational spectrum induced by mitomycin C (MMC), a common DNA interstrand crosslinking agent.
- To identify and confirm genomic lesions resulting from MMC-induced DNA damage.
- To elucidate the DNA repair mechanisms involved in response to MMC.
Main Methods:
- Genetic mapping
- Whole genome sequencing
- Genomic analysis in Caenorhabditis elegans
Main Results:
- Mitomycin C predominantly induces deletions in DNA.
- A 5 acgt-3 sequence context is frequently observed within the deleted regions.
- Microhomology at deletion junctions suggests DNA repair via nonhomologous end joining.
Conclusions:
- The study provides insights into the sequence specificity of mitomycin C-induced DNA damage.
- A general DNA repair mechanism for highly toxic agents like MMC is proposed.
- Findings contribute to understanding the biological response to genotoxic chemotherapeutics.
